- SPHINGOSINE KINASE INHIBITORS
-
The invention relates to substituted adamantane compounds, pharmaceutical compositions thereof, processes for their preparation, and methods for inhibiting sphingosine kinase and for treating or preventing hyperproliferative disease, inflammatory disease, or angiogenic disease.
- -
-
Page/Page column 36; 38
(2008/06/13)
-
- Substituted aryl and aralkyl amides in the treatment of parkinsonism
-
Amides having aromatic substituents of the formula: SPC1 Wherein R is an acyl radical derived from a carboxylic acid having from 3 to 20 carbon atoms, X and Y are members selected from the group consisting of hydrogen, fluoro, trifluoromethyl and hydroxy, and n is an integer selected from the group consisting of 0, 1 and 2, exhibit an effect upon the central nervous system.
- -
-
-